1 |
Messinis DE, Poussin C, Latino DARS, Eb-levadoux Y, Dulize R, Peric D, Guedj E, Titz B, Ivanov NV, Peitsch MC, Hoeng J. Systems biology reveals anatabine to be an NRF2 activator. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1011184] [Reference Citation Analysis]
|
2 |
Ferguson S, McCartan R, Browning M, Hahn-Townsend C, Gratkowski A, Morin A, Abdullah L, Ait-Ghezala G, Ojo J, Sullivan K, Mullan M, Crawford F, Mouzon B. Impact of gulf war toxic exposures after mild traumatic brain injury. Acta Neuropathol Commun 2022;10:147. [PMID: 36258255 DOI: 10.1186/s40478-022-01449-x] [Reference Citation Analysis]
|
3 |
Morin A, Davis R, Darcey T, Mullan M, Mouzon B, Crawford F. Subacute and chronic proteomic and phosphoproteomic analyses of a mouse model of traumatic brain injury at two timepoints and comparison with chronic traumatic encephalopathy in human samples. Mol Brain 2022;15:62. [PMID: 35850691 DOI: 10.1186/s13041-022-00945-4] [Reference Citation Analysis]
|
4 |
Grebenstein PE, Erickson P, Grace M, Kotz CM. Anatabine, Nornicotine, and Anabasine Reduce Weight Gain and Body Fat through Decreases in Food Intake and Increases in Physical Activity. JCM 2022;11:481. [DOI: 10.3390/jcm11030481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|